May 21, 2014 – Aquinox Pharmaceuticals Inc.
Vancouver, British Columbia, May 21, 2014 – Aquinox Pharmaceuticals, Inc. (“Aquinox”, NASDAQ: AQXP), a clinical stage pharmaceutical company discovering and developing targeted therapeutics for inflammatory disease and cancer, today announced that David Main, Aquinox’s Chief Executive Officer, will present at two upcoming investor conferences.
Jefferies 2014 Global Healthcare Conference
Monday, June 2, 2014, at 3:00 P.M. Eastern Time
Grand Hyatt Hotel in New York, NY
A live audio webcast and archive of the event will be available at: http://wsw.com/webcast/jeff82/AQXP
2014 Bloom Burton & Co. Healthcare Investor Conference
Wednesday, June 18, 2014, at 9:30 A.M. Eastern Time
Toronto Board of Trade in Toronto, Canada
The corporate overview being presented at both conferences will be available at http://aqxpharma.com/con- tent/corporate-presentation.
About Aquinox Pharmaceuticals
Aquinox Pharmaceuticals, Inc. is a clinical stage pharmaceutical company discovering and developing novel, small molecule therapeutics targeting SH2-containing inositol-5’-phosphatase 1 (“SHIP1”) for the treatment of inflammatory disease and cancer. For more information please visit www.aqxpharma.com.
Brendan Payne, Senior Manager, Investor Relations
Aquinox Pharmaceuticals, Inc.
MacDougall Biomedical Communications
For Immediate Release AQUINOX PHARMACEUTICALS INC. Web www.aqxpharma.com Suite 450 – 887 Great Northern Way Vancouver, BC, Canada V5T 4T5 Tel 604.629.9223 Fax 778.331.4486 Aquinox Pharmaceuticals to Present at Upcoming Investor Conferences.